Correlation Between Veracyte and Soleno Therapeutics

Can any of the company-specific risk be diversified away by investing in both Veracyte and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Veracyte and Soleno Therapeutics, you can compare the effects of market volatilities on Veracyte and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Soleno Therapeutics.

Diversification Opportunities for Veracyte and Soleno Therapeutics

-0.39

Correlation Coefficient

Veracyte  Soleno Therapeutics

Very good diversification

The 3 months correlation between Veracyte and Soleno is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Soleno Therapeutics go up and down completely randomly.

Pair Corralation between Veracyte and Soleno Therapeutics

Given the investment horizon of 90 days Veracyte is expected to generate 1.12 times more return on investment than Soleno Therapeutics. However, Veracyte is 1.12 times more volatile than Soleno Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Soleno Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  4,276  in Veracyte on October 9, 2024 and sell it today you would earn a total of  65.00  from holding Veracyte or generate 1.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Veracyte  vs.  Soleno Therapeutics

Veracyte

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.

Soleno Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Soleno Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Veracyte and Soleno Therapeutics

The main advantage of trading using opposite Veracyte and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.

The idea behind Veracyte and Soleno Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.